Cadherin-16 (CDH16) Immunohistochemistry: A Novel Diagnostic Tool for Renal Cell Carcinoma and Papillary Carcinomas of the Thyroid

被引:0
|
作者
Lennartz, M. [1 ]
Minner, S. [1 ]
Gorbokon, N. [1 ]
Menz, A. [1 ]
Krech, T. [1 ]
Hoflmayer, D. [1 ]
Simon, R. [1 ]
Blessin, N. C. [1 ]
Sauter, G. [1 ]
Clauditz, T. S. [1 ]
Hinsch, A. [1 ]
机构
[1] Clin Univ Hamburg Eppendorf, Pathol, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:S80 / S80
页数:1
相关论文
共 39 条
  • [31] AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma
    Donate, Fernando
    Raitano, Arthur
    Morrison, Kendall
    An, Zili
    Capo, Linnette
    Avina, Hector
    Karki, Sher
    Morrison, Karen
    Yang, Peng
    Ou, Jimmy
    Moriya, Ryuichi
    Shostak, Yuriy
    Malik, Faisal
    Nadell, Rossana
    Liu, Wendy
    Satpayev, Daulet
    Atkinson, John
    Joseph, Ingrid B. J.
    Pereira, Daniel S.
    Challita-Eid, Pia M.
    Stover, David R.
    CLINICAL CANCER RESEARCH, 2016, 22 (08) : 1989 - 1999
  • [32] Renal oncocytoma with a novel chromosomal rearrangement, der(13)t(13;16)(p11;p11), associated with a renal cell carcinoma
    Leroy, X
    Leteurtre, E
    Mahe, PH
    Gosselin, B
    Delobel, B
    Croquette, MF
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (02) : 157 - 158
  • [33] Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR16-5p
    Feng, Xiaocheng
    Dong, Xuehong
    Wu, Dingting
    Zhao, Hanxin
    Xu, Changqin
    Li, Hong
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (02) : 217 - 224
  • [34] MicroRNA-16 Down-regulates BCL2 Expression and Induces Papillary Thyroid Carcinoma Cell Apoptosis Via Extracellular-regulated Kinase Pathway
    Yang, Jie
    PAKISTAN JOURNAL OF ZOOLOGY, 2020, 52 (05) : 1675 - 1682
  • [35] Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas
    Elisei, R
    Shiohara, M
    Koeffler, HP
    Fagin, JA
    CANCER, 1998, 83 (10) : 2185 - 2193
  • [36] Use of Cytokeratins 10 and 19, p16, and pRb as a Diagnostic Tool for Determining the Primary Site of Cervical Lymph Nodes Metastases of Occult Squamous Cell Carcinoma
    Jung, C. K.
    Park, J. M.
    Choi, Y. J.
    Lee, K. Y.
    Sun, D. I.
    Kim, M. S.
    MODERN PATHOLOGY, 2009, 22 : 249A - 249A
  • [37] Use of Cytokeratins 10 and 19, p16, and pRb as a Diagnostic Tool for Determining the Primary Site of Cervical Lymph Nodes Metastases of Occult Squamous Cell Carcinoma
    Jung, C. K.
    Park, J. M.
    Choi, Y. J.
    Lee, K. Y.
    Sun, D. I.
    Kim, M. S.
    LABORATORY INVESTIGATION, 2009, 89 : 249A - 249A
  • [38] The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma (Expression of Concern of Vol 16, Pg 3628, 2010)
    Cho, Daniel C.
    Cohen, Matthew B.
    Panka, David J.
    Collins, Michael
    Ghebremichael, Musie
    Atkins, Michael B.
    Signoretti, Sabina
    Mier, James W.
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 4194 - 4194
  • [39] Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix
    Xing, Zhao
    Shen, Danhua
    Zhang, Xiaobo
    FRONTIERS IN ONCOLOGY, 2024, 14